Literature DB >> 30002069

Discrepancy in current central serous chorioretinopathy classification.

Sumit Randhir Singh1, Alexandre Matet2,3, Elon H C van Dijk4, Alejandra Daruich5,6, Sascha Fauser7, Suzanne Yzer8, Enrico Peiretti9, Sobha Sivaprasad10, Andrew J Lotery11, Camiel J F Boon4, Francine Behar-Cohen5,6, K Bailey Freund12,13, Jay Chhablani14.   

Abstract

AIM: To report the discordance in central serous chorioretinopathy (CSCR) classification among practising retina specialists.
METHODS: The study conducted was a multicentre survey. Multimodal retinal images along with relevant clinical details of 100 cases diagnosed as CSCR (from six centres) were circulated among six retina specialists across the globe. The image sets included colour fundus photographs, fundus autofluorescence images, optical coherence tomography b-scans, fluorescein and indocyanine green angiography of the study and fellow eyes. The graders were asked to classify the disease of study eye, according to their own criteria. The graders were masked to the responses of other graders. The final analysis of the pooled response data was done based on the diagnosis of study eye only. The main outcome measure was degree of agreement between six independent observers using Fleiss Kappa statistics.
RESULTS: Grading for 100 eyes of 100 patients (men, 93%) was included in the analysis. 20 patients had a history of steroid use. The graders provided 36 different terms to classify the disease, with poor agreement among graders (Fleiss Kappa=0.134). The consistency in diagnosing acute CSCR was statistically higher than for either chronic (p=0.012) or recurrent CSCR (p<0.0001). When collapsing descriptors into six main terms, agreement remained poor (Fleiss Kappa=0.218).
CONCLUSION: The high discordance among experienced retina specialists in describing CSCR clinical subtypes is highlighted. The current work demonstrates the limitations of current empirical CSCR classification methods and the need for a more objective and refined system to bring uniformity in diagnosis and prognostication of the disease. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  central serous chorioretinopathy; fluorescein angiography; fundus autofluorescence; indocyanine green angiography; optical coherence tomography

Year:  2018        PMID: 30002069     DOI: 10.1136/bjophthalmol-2018-312435

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Imaging characteristics of bilateral CSCR cases:12 months follow up.

Authors:  Sumit Randhir Singh; Deepika C Parameswarappa; Supriya Arora; Dmitrii S Maltsev; Niroj Kumar Sahoo; Alexei N Kulikov; Claudio Iovino; Filippo Tatti; Ramesh Venkatesh; Nikitha Gurram Reddy; Ram Snehith Pulipaka; Enrico Peiretti; Jay Chhablani
Journal:  Eye (Lond)       Date:  2022-01-13       Impact factor: 3.775

2.  Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy.

Authors:  Niroj K Sahoo; Deepika C Parameshwarappa; Mahima Jhingan; Filippo Tatti; Claudio Iovino; Enrico Peiretti
Journal:  Cureus       Date:  2022-06-14

3.  FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Jisang Han; Nam Suk Cho; Kiyoung Kim; Eung Suk Kim; Do Gyun Kim; Joon Mo Kim; Seung-Young Yu
Journal:  Retina       Date:  2020-07       Impact factor: 3.975

4.  Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort.

Authors:  Sumit Randhir Singh; Renuka Chakurkar; Abhilash Goud; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

5.  Central Serous Chorioretinopathy Classification.

Authors:  Manuel Vilela; Carolina Mengue
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-30

6.  Fundus Autofluorescence and Optical Coherence Tomography Characteristics in Different Stages of Central Serous Chorioretinopathy.

Authors:  Mary Ho; Stephanie H W Kwok; Andrew C Y Mak; Frank H P Lai; Danny S C Ng; Li Jia Chen; Lawrence P Iu; Alvin L Young; Marten Brelen
Journal:  J Ophthalmol       Date:  2021-05-31       Impact factor: 1.909

Review 7.  Pachychoroid: current concepts on clinical features and pathogenesis.

Authors:  Veronica Castro-Navarro; Francine Behar-Cohen; Woohyok Chang; Antonia M Joussen; Timothy Y Y Lai; Rafael Navarro; Ian Pearce; Yasuo Yanagi; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-15       Impact factor: 3.117

8.  Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium.

Authors:  Hakan Kaymak; Saskia Funk; Andreas Fricke; Roxana Fulga; Karsten Klabe; Berthold Seitz; Achim Langenbucher; Hartmut Schwahn
Journal:  Int J Retina Vitreous       Date:  2020-06-04

9.  Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy.

Authors:  A Matet; T Jaworski; E Bousquet; J Canonica; C Gobeaux; A Daruich; M Zhao; M Zola; M Meester-Smoor; D Mohabati; F Jaisser; S Yzer; F Behar-Cohen
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

10.  Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy.

Authors:  Thomas J van Rijssen; Elon H C van Dijk; Paula Scholz; Robert E MacLaren; Sascha Fauser; Susan M Downes; Carel B Hoyng; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.